Blogs: In the Trenches

Turning Science into Story for Investors, Analysts, and Advocates For an emerging biotech company, the period leading…

The Value of “Normal Course of Business” Communications During the IPO Quiet Period When a company enters…

Building the Discipline Before You Need It For companies preparing to go public, nothing tests credibility faster…

Four phases to public listing success in a challenging market environment As companies navigate a route to…